After more than seven years of visionary leadership, our founder, Tom Lemberg, is passing the torch of leadership to longtime COO Storm Stillman, who will serve as the new CEO. Tom built Curebase from the ground up, redefining how clinical trials are conducted. His dedication to developing modern, user-friendly software has streamlined trials, enhanced patient experiences, and significantly impacted the industry.

‍

While this marks the end of an era, it also signals an exciting new chapter. Effective immediately, Storm Stillman assumes the role of CEO. Stillman brings extensive leadership experience, having been integral to Curebase for nearly six years, most recently serving as Chief Operating Officer.

‍

"I am honored to build upon the incredible foundation Tom has created," said Stillman. "Having partnered closely with him for almost six years, I'm deeply committed to our mission and eager to lead Curebase into our next phase of innovation and growth, while preserving the user-focused ethos that defines us."

‍

Reflecting on this transition, Tom shared, "I know that Storm is the perfect leader for our next chapter, and I'm thrilled for him to take the torch of our mission to modernize research and improve lives for patients."

‍

This leadership transition aligns seamlessly with Curebase's continued growth and expanding market presence, leveraging our comprehensive, AI-native eClinical platform across eCOA/ePRO, eConsent, EDC, and patient engagement solutions. Under Stillman's leadership, Curebase remains dedicated to modernizing clinical research software, enhancing usability, and delivering superior outcomes. Moving forward, Curebase will place an increased emphasis on supporting clinical sites, actively seeking ways to streamline workflows and make their jobs easier and more efficient. Stay tuned for some exciting announcements coming soon!

‍

For further information about Curebase or our leadership team, visit curebase.com or reach out directly at hello@curebase.com.

‍

‍About Curebase

‍Curebase is dedicated to advancing health outcomes through modern, user-friendly eClinical software. Our AI-native platform transforms clinical research with exceptional usability and innovation. Featuring ultraconfigurable tools—including ePRO/eCOA, eConsent, and EDC—our platform integrates AI at its core to facilitate rapid study launches, capture high-quality data, and maximize patient engagement.